Instituto Do Cancer Do Estado De São Paulo
Clinical trials sponsored by Instituto Do Cancer Do Estado De São Paulo, explained in plain language.
-
New combo therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis early-stage trial tests a combination of two drugs—docetaxel (chemotherapy) and a radioactive compound called 177Lu-PSMA-I&T—in men with advanced prostate cancer that no longer responds to hormone therapy. The goal is to find the safest dose of docetaxel when used with the r…
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New biopsy method may spare breast cancer patients from unnecessary surgery
Diagnosis Not yet recruitingThis study tests whether a vacuum-assisted biopsy can accurately tell if breast cancer has been completely eliminated by chemotherapy, compared to the standard surgical removal. About 100 women with breast cancer who have finished chemotherapy will receive the biopsy, and results…
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New robot arm takes on cancer surgery – first safety check begins
Knowledge-focused Not yet recruitingThis study will test a new robotic surgery platform called RonovoTM in 40 adults with cancer who need elective surgery. The robot helps surgeons perform minimally invasive procedures in digestive, thoracic, urology, and gynecology areas. Researchers will track complications, tech…
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study hopes to catch cervical cancer recurrence earlier with HPV testing
Knowledge-focused Not yet recruitingThis study will follow 100 people with advanced cervical cancer who are getting radiation and chemo. Researchers want to see if checking for HPV and other markers in the blood and cervix can better predict if the cancer will come back. The goal is to find recurrences earlier and …
Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC